clinical trial · NCT07059793
MITRIS China Post Market Clinical Follow-up (PMCF) Study
Edwards Lifesciences·—·recruiting·n = 250
Mitral Valve ReplacementMITRIS RESILIA Mitral Valve
brief summary
Collect clinical outcomes on acute and long-term safety and performance of the MITRIS RESILIA Mitral Valve, Model 11400M, in subjects requiring replacement of their native or prosthetic mitral valve with or without concomitant procedures.
started
Jul 8, 2025
primary completion
Dec 1, 2028
completion
Dec 1, 2038
last updated
Dec 30, 2025
detailed description
The trial is a Multicenter, prospective, single-arm, post-market study designed to collect clinical outcomes in up to 250 Subjects who have received the MITRIS RESILIA Mitral Valve, Model 11400M.
official title
Post-Market Clinical Follow-up Study of Edwards Lifesciences MITRIS RESILIA Mitral Valve in Chinese Population
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol